IL136237A0 - Process for the preparation of 6-0-methyl erythromycin a using 9-hydroxy erythromycin derivatives - Google Patents

Process for the preparation of 6-0-methyl erythromycin a using 9-hydroxy erythromycin derivatives

Info

Publication number
IL136237A0
IL136237A0 IL13623798A IL13623798A IL136237A0 IL 136237 A0 IL136237 A0 IL 136237A0 IL 13623798 A IL13623798 A IL 13623798A IL 13623798 A IL13623798 A IL 13623798A IL 136237 A0 IL136237 A0 IL 136237A0
Authority
IL
Israel
Prior art keywords
erythromycin
hydroxy
methyl
preparation
derivatives
Prior art date
Application number
IL13623798A
Other languages
English (en)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of IL136237A0 publication Critical patent/IL136237A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL13623798A 1997-12-16 1998-11-17 Process for the preparation of 6-0-methyl erythromycin a using 9-hydroxy erythromycin derivatives IL136237A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/991,648 US5892008A (en) 1997-12-16 1997-12-16 Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
PCT/US1998/024498 WO1999031114A1 (en) 1997-12-16 1998-11-17 Process for the preparation of 6-o-methyl erythromycin a using 9-hydroxy erythromycin derivatives

Publications (1)

Publication Number Publication Date
IL136237A0 true IL136237A0 (en) 2001-05-20

Family

ID=25537423

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13623798A IL136237A0 (en) 1997-12-16 1998-11-17 Process for the preparation of 6-0-methyl erythromycin a using 9-hydroxy erythromycin derivatives

Country Status (13)

Country Link
US (1) US5892008A (ja)
EP (1) EP1044209B1 (ja)
JP (1) JP2002508385A (ja)
KR (1) KR20010033178A (ja)
AT (1) ATE273988T1 (ja)
AU (1) AU1526999A (ja)
CA (2) CA2615701A1 (ja)
DE (1) DE69825785T2 (ja)
DK (1) DK1044209T3 (ja)
ES (1) ES2229552T3 (ja)
IL (1) IL136237A0 (ja)
PT (1) PT1044209E (ja)
WO (1) WO1999031114A1 (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3054699B2 (ja) * 1998-08-07 2000-06-19 工業技術院長 Ｏ−シリル化含水酸基環状エーテルの製造方法
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
KR20020070991A (ko) 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
HUP0204252A3 (en) 2000-01-11 2003-04-28 Teva Pharma Process for preparing clarithromycin polymorphs and pharmaceutical compositions containing them
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2001064224A1 (en) * 2000-02-29 2001-09-07 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
US6605707B1 (en) 2000-03-23 2003-08-12 Abbott Laboratories Process for the preparation of 6-O-propargyl erythromycin derivatives
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
AU2004258944B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007502296A (ja) * 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
US8062672B2 (en) * 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005023184A2 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2006014427A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
US5872229A (en) * 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives

Also Published As

Publication number Publication date
AU1526999A (en) 1999-07-05
CA2315209C (en) 2008-04-08
CA2615701A1 (en) 1999-06-24
DE69825785D1 (de) 2004-09-23
PT1044209E (pt) 2004-11-30
EP1044209B1 (en) 2004-08-18
ATE273988T1 (de) 2004-09-15
KR20010033178A (ko) 2001-04-25
EP1044209A1 (en) 2000-10-18
WO1999031114A1 (en) 1999-06-24
JP2002508385A (ja) 2002-03-19
ES2229552T3 (es) 2005-04-16
DK1044209T3 (da) 2004-11-22
DE69825785T2 (de) 2005-08-18
US5892008A (en) 1999-04-06
CA2315209A1 (en) 1999-06-24

Similar Documents

Publication Publication Date Title
IL136237A0 (en) Process for the preparation of 6-0-methyl erythromycin a using 9-hydroxy erythromycin derivatives
CA2279932A1 (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
DE69717613D1 (en) 2'-geschützter 3'-dimethylamin, 9-etheroxim erythromycin a derivate
MX9801859A (es) Nuevos derivados de 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion para la preparacion de productos biologicamente activos.
HUP0002252A3 (en) 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them
IL135517A0 (en) Chemical synthesis of 6-0-alkyl erythromycin a
ES8203962A1 (es) Un procedimiento para la preparacion de una macrolida
CZ20011622A3 (cs) Nové deriváty erythromycinu, způsob jejich přípravy a jejich použití jako léčiv
HUP0104600A3 (en) Novel intermediates, process for preparing macrolide antibiotic agent therefrom
IE821260L (en) Anthracycline derivatives
WO2000061594A3 (de) Nucleosid-derivate mit photolabilen schutzgruppen
ES2079436T3 (es) Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
IL110968A0 (en) Nucleosides, nucleotides and oligonucleotides comprising tris-4,4',4"-tert-butylphenylmethyl, as protected group and their preparation
CA2355102A1 (en) Antiparasitic formulations comprising doramectin
AU2978700A (en) Oxyalkylene-substituted aminophenol intermediate
IE883358L (en) Ethylated avermectins
WO1997013776A3 (fr) Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
IL159004A0 (en) An arylation method for the functionalization of o-allyl erythromycin derivatives
EP0325462A3 (en) Anthelmintic milbemycin derivatives
AU3809393A (en) A strain of (streptomyces avermitilis) glycosylates avermectin compounds
EP0311694A4 (en) Nucleoside derivatives and process for their preparation
BG103726A (en) New hydroxyderivatives of tylosin and method for their preparation
ES8700268A1 (es) Un procedimiento para la preparacion de compuestos de eritromicina 6-0, 11-0, 6-11-di-0-alquilados.
GB2171991B (en) Novel macrolide derivatives, process for preparing same, and antibacterial compositions thereof
CA2250736A1 (en) 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin a derivatives